Anesthesia Professionals Not Sufficiently Aware of Risks of Postoperative Cognitive Side Effects
New York, NY, August 19, 2014
Survey of Swedish anesthesia personnel reveals
need to improve knowledge, particularly in elderly and fragile patients, reports
Annals of Medicine and Surgery
Survey of Swedish anesthesia personnel reveals need to improve knowledge, particularly in elderly and fragile patients, reports Annals of Medicine and Surgery
Postsurgical cognitive side effects can have major
implications for the level of care, length of hospital stay, and the patient's
perceived quality of care, especially in elderly and fragile patients. A
nationwide survey of Swedish anesthesiologists and nurse anesthetists has found
there is low awareness of the risks of cognitive side effects following
surgery. Furthermore, only around half of the respondents used
depth-of-anesthesia monitors. Results are published in Annals of Medicine and Surgery.
Patients generally expect to make a rapid recovery from anesthesia with a minimum of side effects. The main focus by anesthesia personnel centers around how to minimize cardiovascular and pulmonary risks and on the management of postoperative pain, nausea, and vomiting. According to the survey results, less attention is being paid to cognitive side effects following surgery, yet these complications can have major implications for the patient.
"We found that Swedish anesthesia personnel viewed risk assessment, prevention, and handling of postoperative delirium and postoperative cognitive dysfunction of rather low importance. Protocol and/or standardized routines were only rarely implemented," observes senior investigator Professor Jan G. Jakobsson, MD, PhD, of the Department of Anesthesia & Intensive Care, Institute for Physical Science, Karolinska Institute, Stockholm, Sweden.
Postoperative cognitive impairments may arise early on after surgery, such as the short-lasting, but still distressful postoperative emergence agitation (EA). Postoperative delirium (POD) usually makes its debut one or two days after surgery, sometimes giving rise to major concerns. The more subtle but longer lasting postoperative cognitive dysfunction (POCD) generally starts during the first week after surgery, but may last for a month. Although these side effects are of major concern for both hospitals and patients, they have received less attention from anesthesia personnel.
To gain insight regarding routines and practice for risk assessment, diagnosis, and management of postoperative cognitive side effects, and the use of EEG-based depth-of-anesthesia monitoring (DOA), investigators sent a web-based validated questionnaire to over 2,500 Swedish anesthesiologists and nurse anesthetists. The questionnaire consisted of three sections covering subjective preferences, routines, and practices related to the perioperative handling of EA, POD, POCD, and awareness. The response rate was 52%.
In general the respondents considered the risk for neurocognitive side effects to be the least important during the preoperative assessment, while the risk of awareness with recall (when patients are able to recall the surgery) as well as traditional cardiac and pulmonary risk was considered of high importance.
It has been suggested that the use of EEG-based DOA monitoring to fine-tune and tailor anesthetic delivery can reduce the risk of postoperative cognitive side effects. Previous surveys of anesthetic practice in Sweden showed a high degree of standardization and that structured protocols for the perioperative management are in place. However, the results of this survey were more diverse. EEG-based DOA monitors were used in half of all departments, but the frequency and indication for their use varied.
"Respondents were overall quite skeptical about the value of EEG-based DOA monitors, however their use in patients at risk for awareness was more positive among the nurse anesthetists than the anesthesiologists," notes Professor Jakobsson. "This attitude to DOA monitoring may be due to the rather negative stance of the Swedish Council on Health Technology Assessment regarding these devices. This is in contrast to the national guidelines in the UK, which support the use of DOA monitoring in at-risk patients."
"The results show there is a need to improve the knowledge of anesthesia personnel about risk factors, prevention and management of postoperative cognitive side effects," concludes Professor Jakobsson.
Notes for editors
"Postoperative management in order to minimise postoperative delirium and postoperative cognitive dysfunction: Results from a Swedish web-based survey," by Pether Jildenstål, CRNA, PhD; Narinder Rawal, MD, PhD, FRCA (Hon), EDRA; Jan Hallén, MD; Lars Berggren, MD, PhD; and Jan G. Jakobsson, MD, PhD. DOI: http://dx.doi.org/10.1016/j.amsu.2014.07.001, Annals of Medicine and Surgery, Volume 3, Issue 3, published online in advance of issue by Elsevier.
While under embargo full text of the article is available to credentialed journalists upon request; contact Allan Ross at via email@example.com to obtain copies. Journalists wishing to interview Professor Jan G. Jakobsson may contact him directly at +46 8 123 55 000 or firstname.lastname@example.org.
About Annals of Medicine and Surgery®
Annals of Medicine and Surgery (AMS) is an online-only, peer-reviewed, open access journal with a global outlook and focus on those training in medicine and surgery (postgraduate and undergraduate). AMS contains a rich mix of original clinical and basic science research, reviews, editorials, commentary, perspectives, debate, opinion, case reports, and journal club reports. Annals of Medicine and Surgery is owned by Surgical Associates Ltd.
Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions — among them ScienceDirect, Scopus, Elsevier Research Intelligence, and ClinicalKey — and publishes nearly 2,200 journals, including The Lancet and Cell, and over 25,000 book titles, including a number of iconic reference works.
The company is part of Reed Elsevier Group PLC, a world leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).
Allan Ross, Publisher